OR23-04 Treatment Of Chronic Hypoparathyroidism With Eneboparatide (AZP-3601), A Novel PTH 1 Receptor Agonist: Results From A Phase 2 Trial

Disclosure: P. Kamenicky: Consulting Fee; Self; consultant. I. Takacs: Consulting Fee; Self; consultant. E. Mezosi: None. A. Soto: None. L. Figueres: None. S. Lemoine: None. F. Borson-Chazot: None. I. Capel: None. M.A. Galvez moreno: None. M. Ovize: Employee; Self; employee. T. OuldRouis: Employee;...

Descripción completa

Detalles Bibliográficos
Autores principales: Kamenicky, Peter, Takacs, Istvan, Mezosi, Emese, Soto, Alfonso, Figueres, Lucile, Lemoine, Sandrine, Borson-Chazot, Francoise, Capel, Ismael, Angeles Artazcoz Galvez Moreno, Maria Angeles, Ovize, Michel, OuldRouis, Taha, Allas, Soraya, Sumeray, Mark, Mannstadt, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Bone And Mineral Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553982/
http://dx.doi.org/10.1210/jendso/bvad114.562

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553982/
http://dx.doi.org/10.1210/jendso/bvad114.562

Ejemplares similares